ORYZF: Oryzon Genomics S.A. Stock

SIC 8731 – Commercial Physical and Biological Research

Valuation
Market Cap ($M) 109.29
Enterprise Value ($M) n/a
Book Value ($M) 87.04
Book Value / Share 1.12
Price / Book n/a
NCAV ($M) -12.93
NCAV / Share -0.17
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.04
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.06

Liquidity (mrq)
Quick Ratio 0.74
Current Ratio 0.75

Balance Sheet (mrq) ($M)
Current Assets 8.75
Assets 108.72
Liabilities 21.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.36
Operating Income -4.50
Net Income -3.67

Cash Flow Statement (mra) ($M)
Cash From Operations -5.69
Cash from Investing -7.81
Cash from Financing 6.87

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
LUNA – Luna Innovations Incorporated MRPI – Mera Pharmaceuticals, Inc.
OHCS – Optimus Healthcare Services, Inc. PXMTF – PHAXIAM Therapeutics S.A.
SGSOF – SGS SA


Financial data and stock pages provided by
Fintel.io